Ioan Paul Voicu

Dr. Ioan Paul Voicu

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Therapeutic Advances in Neurological Disorders
Verified
Journal Article
Open access
PDF file
GCGiovanna-Stefania Colafati
Giovanna-Stefania Colafati
Ioan Paul VoicuIoan Paul Voicu
Ioan Paul Voicu
CCChiara Carducci
Chiara Carducci
Evelina MieleEvelina Miele
Evelina Miele
Andrea CaraiAndrea Carai
Andrea Carai
AMAngela Mastronuzzi
Angela Mastronuzzi
Medulloblastoma is the most common malignant pediatric brain tumor. Medulloblastoma should not be viewed as a single disease, but as a heterogeneous mixture of various subgroups with distinct characteristics. Based on genomic profiles, four distinct molecular subgroups are identified: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Group 4. Each of these subgroups are associated with specific genetic aberrations, typical age of onset as well as survival prognosis. Magnetic resonance imaging (MRI) is performed for all patients with brain tumors, and has a key role in the diagnosis, surgical guidance and follow up of patients with medulloblastoma. Several studies indicate MRI as a promising tool for early detection of medulloblastoma subgroups. The early identification of the subgroup can influence the extent of surgical resection, radiotherapy and chemotherapy targeted treatments. In this article, we review the state of the art in MRI-facilitated medulloblastoma subgrouping, with a summary of the main MRI features in medulloblastoma and a brief discussion on molecular characterization of medulloblastoma subgroups. The main focus of the article is MRI features that correlate with medulloblastoma subtypes, as well as features suggestive of molecular subgroups. Finally, we briefly discuss the latest trends in MRI studies and latest developments in molecular characterization.

4 April 2019 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
GCGiovanna-Stefania Colafati
Giovanna-Stefania Colafati
Ioan Paul VoicuIoan Paul Voicu
Ioan Paul Voicu
CCChiara Carducci
Chiara Carducci
MCMassimo Caulo
Massimo Caulo
Maria VinciMaria Vinci
Maria Vinci
Angela MastronuzziAngela Mastronuzzi
Angela Mastronuzzi
Background: Diffuse intrinsic pontine glioma (DIPG) has a dismal prognosis. Magnetic resonance imaging (MRI) remains the gold standard for non-invasive DIPG diagnosis. MRI features have been tested as surrogate biomarkers. We investigated the direct involvement of cranial nerve V (CN V) in DIPG at diagnosis and its utility as predictor of poor overall survival. Materials and Methods: We examined MRI scans of 35 consecutive patients with radiological diagnosis of DIPG. Direct involvement of CN V was assessed on the diagnostic scans. Differences in overall survival (OS) and time to progression (TTP) were analyzed for involvement of CN V, sex, age, tumor size, ring enhancement, and treatment regimen. Correlations between involvement of CN V and disease dissemination, magnet strength and slice thickness were analyzed. Statistical analyses included Kaplan-Meier curves, log-rank test and Spearman's Rho. Results: After excluding six long-term survivors, 29 patients were examined (15 M, 14 F). Four patients presented direct involvement of CN V. Histological data were available in 12 patients. Median OS was 11 months (range 3–23 months). Significant differences in OS were found for direct involvement of CN V (median OS: 7 months, 95% CI 1.1–12.9 months for involvement of CN V vs. 13 months, 95% CI 10.2–15.7 for lack of involvement of CN V, respectively, p < 0.049). Significant differences in TTP were found for the two treatment regimens (median TTP: 4 months, 95% CI 2.6–5.3 vs. 7 months, 95% CI 5.9–8.1, respectively, p < 0.027). No significant correlation was found between involvement of CN V and magnet strength or slice thickness (r = −0.201; p = NS). A trend toward positive correlation was found between direct involvement of CN V at diagnosis and dissemination of disease at follow-up (r = 0.347; p < 0.065). Conclusions: In our cohort, direct involvement of CN V correlated with poor prognosis. Based on our data, we suggest that in DIPG direct involvement of CN V should be routinely evaluated on diagnostic scans.

16 May 2017 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
SBSaide Di Biase
Saide Di Biase
MTMarianna Trignani
Marianna Trignani
Luciana CaravattaLuciana Caravatta
Luciana Caravatta
Ioan Paul VoicuIoan Paul Voicu
Ioan Paul Voicu
CCClelia Di Carlo
Clelia Di Carlo
DGDomenico Genovesi
Domenico Genovesi

25 July 2018 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
GCGiovanna-Stefania Colafati
Giovanna-Stefania Colafati
EREnrica Rossi
Enrica Rossi
CCChiara Carducci
Chiara Carducci
SPSimone Piga
Simone Piga
Ioan Paul VoicuIoan Paul Voicu
Ioan Paul Voicu
PTPaolo Toma
Paolo Toma

29 September 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Ioan Paul VoicuIoan Paul Voicu
Ioan Paul Voicu
Antonio NapolitanoAntonio Napolitano
Antonio Napolitano
MCMassimo Caulo
Massimo Caulo
FDFrancesco Dotta
Francesco Dotta
EPEleonora Piccirilli
Eleonora Piccirilli
GCGiovanna-Stefania Colafati
Giovanna-Stefania Colafati
Purpose: To develop a predictive grading model based on diffusion kurtosis imaging (DKI) metrics in children affected by gliomas, and to investigate the clinical impact of the predictive model by correlating with overall survival and progression-free survival. Materials and methods: 59 patients with a histological diagnosis of glioma were retrospectively studied (33 M, 26 F, median age 7.2 years). Patients were studied on a 3T scanner with a standardized MR protocol, including conventional and DKI sequences. Mean kurtosis (MK), axial kurtosis (AK), radial kurtosis (RK), fractional anisotropy (FA), and apparent diffusion coefficient (ADC) maps were obtained. Whole tumour volumes (VOIs) were segmented semi-automatically. Mean DKI values were calculated for each metric. The quantitative values from DKI-derived metrics were used to develop a predictive grading model to develop a probability prediction of a high-grade glioma (pHGG). Three models were tested: DTI-based, DKI-based, and combined (DTI and DKI). The grading accuracy of the resulting probabilities was tested with a receiver operating characteristics (ROC) analysis for each model. In order to account for dataset imbalances between pLGG and pHGG, we applied a random synthetic minority oversampling technique (SMOTE) analysis. Lastly, the most accurate model predictions were correlated with progression-free survival (PFS) and overall survival (OS) using the Kaplan–Meier method. Results: The cohort included 46 patients with pLGG and 13 patients with pHGG. The developed model predictions yielded an AUC of 0.859 (95%CI: 0.752–0.966) for the DTI model, of 0.939 (95%CI: 0.879–1) for the DKI model, and of 0.946 (95%CI: 0.890–1) for the combined model, including input from both DTI and DKI metrics, which resulted in the most accurate model. Sample estimation with the random SMOTE analysis yielded an AUC of 0.98 on the testing set. Model predictions from the combined model were significantly correlated with PFS (25.2 months for pHGG vs. 40.0 months for pLGG, p < 0.001) and OS (28.9 months for pHGG vs. 44.9 months for pLGG, p < 0.001). Conclusions: a DKI-based predictive model was highly accurate for pediatric glioma grading. The combined model, derived from both DTI and DKI metrics, proved that DKI-based model predictions of tumour grade were significantly correlated with progression-free survival and overall survival.

3 February 2020 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Closed access
PDF file
Ioan Paul VoicuIoan Paul Voicu
Ioan Paul Voicu
TBTommaso Bartalena
Tommaso Bartalena